Halozyme Therapeutics Receives Favorable FDA Decision By: Benzinga via Benzinga July 31, 2014 at 14:45 PM EDT Halozyme Therapeutics (NASDAQ: HALO) received notice Thursday that the Blood Products Advisory Committee (BPAC) of the U.S. Food and ... Read More >> Related Stocks: Baxter International Halozyme Therapeutic